Diuretics

"Diuretics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents that promote the excretion of urine through their effects on kidney function.

Descriptor ID	D004232
MeSH Number(s)	D27.505.696.560.500
Concept/Terms	Diuretics Diuretics Diuretic Diuretic Effect Diuretic Effect Effect, Diuretic Diuretic Effects Effects, Diuretic

Below are MeSH descriptors whose meaning is more general than "Diuretics".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Natriuretic Agents [D27.505.696.560]
Diuretics [D27.505.696.560.500]

Below are MeSH descriptors whose meaning is related to "Diuretics".

Below are MeSH descriptors whose meaning is more specific than "Diuretics".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Diuretics" by people in this website by year, and whether "Diuretics" was a major or minor topic of these publications.

Bar chart showing 45 publications over 21 distinct years, with a maximum of 6 publications in 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	0	3	3
2000	3	2	5
2001	0	1	1
2002	0	2	2
2003	1	2	3
2004	0	2	2
2005	1	2	3
2007	2	4	6
2008	0	1	1
2009	0	2	2
2010	1	1	2
2011	2	0	2
2013	0	2	2
2014	0	1	1
2015	1	1	2
2016	1	1	2
2017	0	1	1
2019	2	0	2
2020	1	0	1
2023	0	1	1
2025	0	1	1

Below are the most recent publications written about "Diuretics" by people in Profiles.

Gudushauri N, Polintan ET, Lemonjava I, Menghrajani RH, Alfonso PG, Shah S, Azmaiparashvili Z, Lo KB, Rangaswami J. Torsemide vs. furosemide in congestive heart failure: a systematic-review and meta-analysis on mortality and rehospitalization. Acta Cardiol. 2025 Jun; 80(4):351-357.

View in: PubMed
Bamat NA, Huber M, Shults J, Li Y, Zong Z, Zuppa A, Eichenwald EC, Laughon MM, DeMauro SB, McKenna KJ, Laskin B, Lorch SA. Diuretic Tolerance to Repeated-Dose Furosemide in Infants Born Very Preterm with Bronchopulmonary Dysplasia. J Pediatr. 2024 03; 266:113813.

View in: PubMed
Hampson AJ, Schroeder JR, Ellefsen KN, Yammine L, Epstein DH, Preston KL, Huestis MA, Verrico CD. Subtherapeutic Acetazolamide Doses as a Noninvasive Method for Assessing Medication Adherence. Clin Pharmacol Ther. 2020 12; 108(6):1203-1212.

View in: PubMed
Drori T, Abu-Ghanem Y, Kleinmann N, Shvero A, Winkler HZ, Zilberman DE. [A COMPARISON BETWEEN TWO POTASSIUM CITRATE REGIMENS FOR THE TREATMENT OF NEPHROLITHIASIS]. Harefuah. 2019 Dec; 158(12):774-777.

View in: PubMed
Chang AM, Pang PS, Butler J, Storrow AB, Levy PD, Lindenfeld J, Collins SP. Early Treatment in Emergency Department Patients with Acute Heart Failure: Does Time Matter? Curr Heart Fail Rep. 2019 02; 16(1):12-20.

View in: PubMed
Mysliwiec M, Bonita RE. Outpatient Emergencies: Acute Heart Failure. Med Clin North Am. 2017 May; 101(3):507-519.

View in: PubMed
Kwok CS, Wong CW, Rushton CA, Ahmed F, Cunnington C, Davies SJ, Patwala A, Mamas MA, Satchithananda D. Ultrafiltration for acute decompensated cardiac failure: A systematic review and meta-analysis. Int J Cardiol. 2017 Feb 01; 228:122-128.

View in: PubMed
Collins SP, Levy PD, Martindale JL, Dunlap ME, Storrow AB, Pang PS, Albert NM, Felker GM, Fermann GJ, Fonarow GC, Givertz MM, Hollander JE, Lanfear DE, Lenihan DJ, Lindenfeld JM, Peacock WF, Sawyer DB, Teerlink JR, Butler J. Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society for Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group. Acad Emerg Med. 2016 08; 23(8):922-31.

View in: PubMed
Cies JJ, Moore WS, Chopra A, Lu G, Mason RW. Stability of furosemide and chlorothiazide stored in syringes. Am J Health Syst Pharm. 2015 Dec 15; 72(24):2182-8.

View in: PubMed
Givertz MM, Anstrom KJ, Redfield MM, Deswal A, Haddad H, Butler J, Tang WH, Dunlap ME, LeWinter MM, Mann DL, Felker GM, O'Connor CM, Goldsmith SR, Ofili EO, Saltzberg MT, Margulies KB, Cappola TP, Konstam MA, Semigran MJ, McNulty SE, Lee KL, Shah MR, Hernandez AF. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study. Circulation. 2015 May 19; 131(20):1763-71.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement